(1,3-Dimethyl-1H-indazol-5-yl)boronic acid, 95.0%, 500mg

(3aR,6R,6aR)-2,2-Dimethyl-6-vinyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 1g

N~1~-(3-amino-4-methylphenyl)-N~2~,N~2~-dimethylglycinamide dihydrochloride, 95.0%, 5g

METHYL 5-OXO-7-(((TRIFLUOROMETHYL)SULFONYL)OXY)-1,2,3,5-TETRAHYDROINDOLIZINE-3-CARBOXYLATE, 95.0%, 500mg

Imidazo[1,2-b]pyridazin-3-amine, 95.0%, 500mg

Potassium (S)-2-aminosuccinate, 95.0%, 25g

2-Chloro-4,6-bis(trifluoromethyl)pyridine, 98%, 250mg

4-{[(benzyloxy)carbonyl]amino}-3-(4-chlorophenyl)butanoic acid, 1g

(4S,4'S)-1,1'-Bis(4-(tert-butyl)phenyl)-4,4'-diisopropyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

2,3-Difluoropyridin-4-amine, 97.0%, 1g

Solution étalon multi-éléments ICP-MS, 28 éléments dans acide nitrique 5% - 10 mg/L

2,4-Dichloro-6-(trifluoromethoxy)quinoline, 98%, 100mg

methyl 2-chloro-5-hydroxypyridine-3-carboxylate, 95.0%, 5g